<![CDATA[fda and ide Resources | BNET]]> en-us <![CDATA[Spinal Restoration, Inc. Receives FDA IDE Approval]]> Tue, 13 May 2008 00:00:00 -0700 <![CDATA[Imaging3 Receives FDA Approval to Distribute the Dominion Vi Scanner Under FDA (IDE) Regulations]]> Wed, 02 Apr 2008 00:00:00 -0700 <![CDATA[Cook Incorporated Files IDE Application for Zenith Branch Vessel Graft with U.S. FDA]]> Thu, 24 Jan 2008 00:00:00 -0800 <![CDATA[ViaCell Receives IDE Supplement Approval to Advance ViaCyte Pivotal Trial]]> Mon, 09 Jul 2007 00:00:00 -0700 <![CDATA[FDA Grants IDE Approval to TransMedics for the Pilot Phase of the PROCEED Clinical Trial for Its Organ Care System™ - the First System to Support Beating Heart Transplant]]> Thu, 19 Apr 2007 00:00:00 -0700 <![CDATA[CVRx®, Inc., Receives IDE Approval for Rheos™ Baroreflex Hypertension Therapy™ System Pivotal Trial]]> Mon, 16 Oct 2006 00:00:00 -0700 <![CDATA[FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems; Advanced Medical Technology Indicated for Use with Low Cardiac Output after Cardiac Surgery]]> Tue, 27 Jun 2006 00:00:00 -0700 <![CDATA[FDA Approves 'IDE' Clinical Trial of Paradigm Spine's Coflex(TM) Functionally Dynamic Interspinous Implant.]]> Tue, 09 May 2006 00:00:00 -0700 <![CDATA[FDA Approves Further Changes To CORTOSS® IDE Pivotal Study Protocol]]> Mon, 17 Apr 2006 00:00:00 -0700 <![CDATA[Outpatient Procedure for Asthma; Asthmatx Announces the Start of its FDA Approved IDE Study that may Change the Course of Asthma Care]]> Mon, 09 Jan 2006 00:00:00 -0800 <![CDATA[Angiotech Pharmaceuticals: Boston Scientific Submits Amended IDE to FDA for U.S. Clinical Trial of its Paclitaxel-Eluting Coronary Stent System.]]> Wed, 20 Feb 2002 00:00:00 -0800 BSX BSX <![CDATA[Angiotech Pharmaceuticals: Boston Scientific Submits Amended IDE to FDA for U.S. Clinical Trial of Its Paclitaxel-Eluting Coronary Stent System]]> Wed, 20 Feb 2002 00:00:00 -0800 BSX BSX <![CDATA[Angiotech Pharmaceuticals: Boston Scientific Submits IDE to FDA for U.S. Clinical Trial of its Paclitaxel-Eluting Coronary Stent System; Trial is Company's Fourth.]]> Thu, 25 Oct 2001 00:00:00 -0700 BSX BSX <![CDATA[Angiotech Pharmaceuticals: Boston Scientific Submits IDE to FDA for U.S. Clinical Trial of its Paclitaxel-Eluting Coronary Stent System]]> Thu, 25 Oct 2001 00:00:00 -0700 BSX BSX <![CDATA[EndoSonics Submits IDE Application to the FDA for Directional Brachytherapy Device; Cleveland Clinic Foundation is Development Partner]]> Tue, 28 Mar 2000 00:00:00 -0800 <![CDATA[Thoratec Files IDE for Vascular Access Graft; Data Allows FDA to Determine Whether Clinical Trials Can Commence]]> Thu, 04 Dec 1997 00:00:00 -0800 <![CDATA[EP MedSystems Files Alert System IDE With FDA]]> Thu, 21 Aug 1997 00:00:00 -0700 <![CDATA[Cardima, Inc. Receives FDA Approval of IDE for Initial Phase of Atrial Fibrillation Study]]> Wed, 09 Jul 1997 00:00:00 -0700 <![CDATA[Influence announces Investigational Device Exemption - IDE - and grant of expedited review for the In-Flow incontinence product by FDA]]> Wed, 21 May 1997 00:00:00 -0700 <![CDATA[Life Medical Sciences initiates U.S. clinical trials for REPEL; investigational device exemption application approved by FDA - IDE]]> Tue, 18 Feb 1997 00:00:00 -0800